Health Condition 1: N948- Other specified conditions associated with female genital organs and menstrual cycle
Conditions
Interventions
Intervention1: ERAS: 1.Pre-Admission information,education & counselling to alleviate anxiety related to surgery.
2.No mechanical bowel preparation with Peglac and enema.
3.1g Tinidazole day before su
Sponsors
ALL INDIA INSTITUTE OF MEDICAL SCIENCES RISHIKESH
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients aged 30-60 years undergoing Robotic hysterectomy for benign indication 2)Patient who are willing and give consent
Exclusion criteria
Exclusion criteria: 1)Patient not willing to participate in the study 2)Contraindications for neuraxial anesthesia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine if ERAS pathways in robotic hysterectomy shortens the length of hospital stay in days. 1. Fit for discharge in days 2. Time to tolerate of diet in days 3. Time to flatus / defecation in days Timepoint: 1. Post operative complications within 30 days 2. Quality of life on post-op day 2 and after 30 days of surgery 3. Readmission rates within 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of ERAS protocol in: 1. Reducing Postoperative complications 2. Reducing readmissions rate 3. Reduction in time to tolerance of diet 4. Reduction in time to passage of flatus/defecation. 5. Patient satisfaction and the quality of life and its psychological impact. Timepoint: �? Readmission rate within 30 days of discharge �? Quality Of Life by WHO-QOL BREF(Annexure VIII) Patient will be followed up at Post-operative Day 2 and Day 30 considering the day of surgery as Day 0. | — |
Countries
India
Contacts
Public ContactBhawana Kumari Mallick
AIIMS, Rishikesh
Outcome results
None listed